GFDCAV: Performance of the Established Model (which uses atherothrombotic markers, only), with the New Model (which adds inflammatory markers to the Established Model).

Both models were developed using markers obtained from the 1st biopsy only (median 9-days post-op) and markers from all biopsies obtained during the first 3 months to predict the risk of graft failure at 5- or 10-years post-operatively.Abbreviations: GFDCAV: graft failure due to cardiac allograft vasculopathy; PPV: positive predictive value; NPV: negative predictive value.aPct correct: The percentage of cases correctly classified by the model considering both positive and negative classifications.bCutoff value: The predicted value from the logistic regression that serves as the threshold for predicting GFDCAV. Patients with predicted values exceeding the cutoff are predicted to experience GFDCAV.cPrevalence: The proportion of patients that had GFDCAV during the indicated time interval.GFDCAV: Performance of the Established Model (which uses atherothrombotic markers, only), with the New Model (which adds inflammatory markers to the Established Model).